This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
saas: Archive
Should You Buy Central Garden (CENT) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CENTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
US and Israel Conduct Joint Airstrikes on Iran to Eliminate Iran Supreme Leader as the World Watches in Shock
by Mayur Thaker
President Trump reneges on a long-standing promise of avoiding significant military engagement in Iran.
ADBEPositive Net Change SNOWNegative Net Change CRWDNegative Net Change
saas
Should You Buy Kimco Realty (KIM) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
KIMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
LMATNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Are Options Traders Betting on a Big Move in BILL Stock?
by Zacks Equity Research
Investors need to pay close attention to BILL Holdings stock based on the movements in the options market lately.
BILLPositive Net Change
saas tech-stocks
GitLab Set to Report Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
GTLb gears up for Q4 results with revenues seen up 19% Y/Y, as AI-driven DevSecOps, SaaS momentum and strong retention fuel growth.
MUNegative Net Change MDBNegative Net Change GTLBPositive Net Change CRDONegative Net Change
artificial-intelligence saas tech-stocks
Can IBM's New Defense Contract Win Boost Top-Line Growth?
by Zacks Equity Research
IBM wins up to $112 million Defense Commissary Agency deal to modernize pricing at 235 military commissaries, boosting digital ops and expanding its defense AI push.
MSFTPositive Net Change IBMPositive Net Change ORCLNegative Net Change
cloud-computing communications computers saas tech-stocks
After Golden Cross, CMS Energy (CMS)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
CMSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
PSTG Beats on Q4 Earnings & Sales, Enters FY27 With Hyperscale Momentum
by Zacks Equity Research
Pure Storage tops fiscal Q4 2026 estimates with first $1B quarter, 20% revenue jump and upbeat fiscal 2027 outlook as it rebrands as Everpure.
WDCNegative Net Change SNDKNegative Net Change TDCPositive Net Change
artificial-intelligence cloud-computing earnings saas tech-stocks
Arista 2.0 Strategy Picks Up Steam: Can ANET Ride This Wave?
by Supriyo Bose
ANET's Arista 2.0 gains traction as 150M port milestone, AI push and SaaS focus power its next phase of cloud networking growth.
CSCONegative Net Change CIENNegative Net Change ANETNegative Net Change
artificial-intelligence cloud-computing iot saas tech-stocks